Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01947543

Calmodulin Gene Mutations in Patients With Ventricular Arrhythmia of Unknown Origin - A Screening Study

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Region Örebro County · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

The aim of this study is to screen a well characterized patient population with ventricular tachycardia of unknown origin and treated with an implantable cardioverter-defibrillator (ICD) for mutations in the calmodulin genes.

Detailed description

Patients with ventricular tachycardia of unknown origin and treated with an implantable cardioverter-defibrillator (ICD) will be asked to participate in the study. For patients with results showing mutations in the calmodulin genes, family members (parents, siblings and children) will also be asked to participate in the study. For under age patients and relatives who agree to participate, informed consent will also be taken from their custodian.

Conditions

Timeline

Start date
2017-01-01
Primary completion
2018-04-01
Completion
2018-04-01
First posted
2013-09-20
Last updated
2018-04-11

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT01947543. Inclusion in this directory is not an endorsement.

Calmodulin Gene Mutations in Patients With Ventricular Arrhythmia of Unknown Origin - A Screening Study (NCT01947543) · Clinical Trials Directory